Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cancer Genetics Inc (NASDAQ:CGIX)

2.02
Delayed Data
As of Jul 25
 -0.02 / -0.98%
Today’s Change
1.82
Today|||52-Week Range
11.45
-38.79%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues4.2M4.0M5.5M6.1M
 
 
 
 
 
Cost of Goods Sold2.8M2.8M4.1M3.5M
 
 
 
 
 
Depreciation And Amortization340.6K300.4K664.6K605.0K
 
 
 
 
 
 
Operating ExpensesGross Income1.1M897.1K728.6K2.0M
 
 
 
 
 
General Expenses5.3M6.2M7.1M7.1M
 
 
 
 
 
Research And Development1.1M1.5M1.2M1.5M
 
 
 
 
 
Total Operating Expenses8.4M9.3M11.9M11.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.2M-5.3M-6.4M-5.2M
 
 
 
 
 
Extraordinary Credit0.00529.5K421.7K51.0K
 
 
 
 
Extraordinary Charge-497.3K0.00-890.0K--
 
 
 
Pre-Tax Equity Earnings-198.0K-342.8K40.5K--
 
 
 
 
Interest Expense On Debt81.6K111.6K116.9K126.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.0M-5.2M-6.9M-5.3M
 
 
 
 
 
Income Taxes0.000.00-1.2M0.00
 
 
Net Income-5.0M-5.2M-5.7M-5.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS9.7M9.7M12.0M13.5M
 
 
 
 
 
Shares To Calculate EPS Diluted9.7M9.7M12.0M13.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.51-$0.56-$0.48-$0.39
 
 
 
 
 
EPS Diluted-$0.51-$0.56-$0.48-$0.39